{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:11:17Z","timestamp":1769890277323,"version":"3.49.0"},"reference-count":30,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2026,1,25]]},"DOI":"10.23922\/jarc.2025-029","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T22:09:31Z","timestamp":1769292571000},"page":"43-53","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Colostomy after Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Anus: A Nationwide, Multicenter Analysis in Japan"],"prefix":"10.23922","volume":"10","author":[{"given":"Atsushi","family":"Kohyama","sequence":"first","affiliation":[{"name":"Department of Surgery, Tohoku University Graduate School of Medicine"},{"name":"Department of Surgery, Iwaki City Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Ohnuma","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[{"name":"Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Coloproctology Center Takano Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71 (3):209-49.","DOI":"10.3322\/caac.21660"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nelson RA, Levine AM, Bernstein L, et al. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol. 2013 Apr;31 (12):1569-75.","DOI":"10.1200\/JCO.2012.45.2524"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamada K, Saiki Y, Komori K, et al. Characteristics of anal canal cancer in Japan. Cancer Med. 2022 Jul;11 (14):2735-43.","DOI":"10.1002\/cam4.4631"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996 Oct;348 (9034):1049-54.","DOI":"10.1016\/S0140-6736(96)03409-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997 May;15 (5):2040-9.","DOI":"10.1200\/JCO.1997.15.5.2040"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996 Sep;14 (9):2527-39.","DOI":"10.1200\/JCO.1996.14.9.2527"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nigro ND, Vaitkevicius VK, Considine B, Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974 May-Jun;17 (3):354-6.","DOI":"10.1007\/BF02586980"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Quan SH, Magill GB, Leaming RH, et al. Multidisciplinary preoperative approach to the management of epidermoid carcinoma of the anus and anorectum. Dis Colon Rectum. 1978 Mar;21 (2):89-91.","DOI":"10.1007\/BF02586442"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013 May;14 (6):516-24.","DOI":"10.1016\/S1470-2045(13)70086-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schiller DE, Cummings BJ, Rai S, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol. 2007 Oct;14 (10):2780-9.","DOI":"10.1245\/s10434-007-9491-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mullen JT, Rodriguez-Bigas MA, Chang GJ, et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb;14 (2):478-83.","DOI":"10.1245\/s10434-006-9221-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bentzen AG, Guren MG, Wander\u00e5s EH, et al. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort. Int J Radiat Oncol Biol Phys. 2012 Jun;83 (2):e173-80.","DOI":"10.1016\/j.ijrobp.2011.12.062"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Glynne-Jones R, Kadalayil L, Meadows HM, et al. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. Ann Oncol. 2014 Aug;25 (8):1616-22.","DOI":"10.1093\/annonc\/mdu188"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. Jama. 2008 Apr;299 (16):1914-21.","DOI":"10.1001\/jama.299.16.1914"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol. 2012 Dec;30 (35):4344-51.","DOI":"10.1200\/JCO.2012.43.8085"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Peiffert D, Tournier-Rangeard L, G\u00e9rard JP, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol. 2012 Jun;30 (16):1941-8.","DOI":"10.1200\/JCO.2011.35.4837"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ajani JA, Winter KA, Gunderson LL, et al. US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol. 2009 Mar;27 (7):1116-21.","DOI":"10.1200\/JCO.2008.19.6857"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ito Y, Hamaguchi T, Takashima A, et al. Definitive S-1\/mitomycin-C chemoradiotherapy for stage II\/III anal canal squamous cell carcinoma: a phase I\/II dose-finding and single-arm confirmatory study (JCOG0903). Int J Clin Oncol. 2023 Aug;28 (8):1063-72.","DOI":"10.1007\/s10147-023-02361-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kitaguchi D, Tsukada Y, Ito M, et al. Survival outcomes following salvage abdominoperineal resection for recurrent and persistent anal squamous cell carcinoma. Eur J Surg Oncol. 2023 Sep;49 (9):106929.","DOI":"10.1016\/j.ejso.2023.05.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Klopp AH, Enserro D, Powell M, et al. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology\/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Jul;42 (20):2425-35.","DOI":"10.1200\/JCO.23.01279"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sunesen KG, N\u00f8rgaard M, Lundby L, et al. Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study. J Clin Oncol. 2011 Sep;29 (26):3535-40.","DOI":"10.1200\/JCO.2011.36.1790"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol. 2001;2 (6):349-51.","DOI":"10.2165\/00128071-200102060-00001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020 Jun;11 (1):32.","DOI":"10.1186\/s13293-020-00308-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kim J, Ji E, Jung K, et al. Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX. J Pers Med. 2021 Jan;11 (2).","DOI":"10.3390\/jpm11020083"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Elsaleh H, Joseph D, Grieu F, et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet. 2000 May;355 (9217):1745-50.","DOI":"10.1016\/S0140-6736(00)02261-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamada Y, Muro K, Takahashi K, et al. Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial. Glob Health Med. 2020 Aug;2 (4):240-46.","DOI":"10.35772\/ghm.2020.01050"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gunderson LL, Moughan J, Ajani JA, et al. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys. 2013 Nov;87 (4):638-45.","DOI":"10.1016\/j.ijrobp.2013.07.035"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kent C, Bessell EM, Scholefield JH, et al. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate. J Gastrointest Cancer. 2017 Mar;48 (1):1-7.","DOI":"10.1007\/s12029-016-9850-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Martin D, Balermpas P, Winkelmann R, et al. Anal squamous cell carcinoma - State of the art management and future perspectives. Cancer Treat Rev. 2018 Apr;65:11-21.","DOI":"10.1016\/j.ctrv.2018.02.001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gilbert DC, Serup-Hansen E, Linnemann D, et al. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer. Br J Cancer. 2016 Jan;114 (2):134-7.","DOI":"10.1038\/bjc.2015.448"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-029\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:38:38Z","timestamp":1769834318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-029\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2025-029","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"article-number":"2025-029"}}